Logo-jrip
Submitted: 20 Jun 2017
Accepted: 04 Sep 2017
ePublished: 20 Sep 2017
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Renal Inj Prev. 2018;7(3): 215-217.
doi: 10.15171/jrip.2018.50

Scopus ID: 85050151073
  Abstract View: 3286
  PDF Download: 1552

Case Report

Acute kidney injury and posterior reversible encephalopathy syndrome in a boy with β thalassemia major

Hossein Emad Momtaz*

1 Division of Pediatric Nephrology, Besat Hospital, Hamadan University of Medical Sciences, Hamadan, Iran
*Corresponding Author: *Corresponding author: Hossein Emad Momtaz, Email: , Email: hemmtz@yahoo.com

Abstract

Renal involvement in thalassemia major is an important concern of both pediatric nephrologists and pediatric hematologists. Both glomerular and tubular injury may precede overt kidney dysfunction in these patients and may be due to deleterious effects of hemolysis, iron overload and iron chelator therapy. Here we present a case of thalassemia major with acute kidney injury with findings in favor of hemolytic uremic syndrome and consequent posterior reversible encephalopathy syndrome who needed multiple sessions of hemodialysis and finally recovered uneventfully

Implication for health policy/practice/research/medical education:

Patients with β thalassemia major are at risk of renal damage due to multiple mechanisms. Frequent monitoring of kidney function and attention to level of iron overload, dose and duration of chelator therapy is highly recommended in this group of patients.

Please cite this paper as: Momtaz HE. Acute kidney injury and posterior reversible encephalopathy syndrome in a boy with β thalassemia major. J Renal Inj Prev. 2018;7(3):215-217. doi: 10.15171/jrip.2018.50.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 3287

Your browser does not support the canvas element.


PDF Download: 1552

Your browser does not support the canvas element.